Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study

Description

This is a prospective equivalence colonoscopy study evaluating whether overall adenoma detection rate (ADR) is a reliable alternate for screening ADR. Overall indication includes screening, surveillance, and diagnostic indications.

Conditions

Adenoma Detection Rate, Colonoscopy

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a prospective equivalence colonoscopy study evaluating whether overall adenoma detection rate (ADR) is a reliable alternate for screening ADR. Overall indication includes screening, surveillance, and diagnostic indications.

Improving Colonoscopy Adenoma Detection Metrics by Extending the Screening-only Measurement to All Indications: a Prospective Multicenter Study

Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study

Condition
Adenoma Detection Rate
Intervention / Treatment

-

Contacts and Locations

North Hills

Sepulveda Ambulatory Care Center, VAGLAHS, North Hills, California, United States, 91343

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * consecutive patients aged ≥50 years undergoing colonoscopy are eligible for enrollment.
  • * high risk family history of colorectal cancer (CRC) e.g., familial adenomatous polyposis, hereditary non-polyposis CRC syndrome, multiple first degree relatives with CRC, or a single first degree relative with CRC at \<60 years
  • * serrated polyposis syndrome
  • * inflammatory bowel disease
  • * colonoscopy to remove a large neoplastic polyps
  • * obstructive lesions of the colon
  • * gastrointestinal bleeding
  • * current participation in other studies
  • * hospitalized patients
  • * mental retardation
  • * pregnancy
  • * refusal to provide a written informed consent.

Ages Eligible for Study

50 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Evergreen General Hospital, Taiwan,

Chi-Liang Cheng, PRINCIPAL_INVESTIGATOR, Evergreen General Hospital, Taoyuan, Taiwan

Study Record Dates

2025-08-31